Role of oxidative stress in arsenic-induced toxicity

Drug Metabolism Reviews

Volumn 38, Issue 4, 2006, Pages 791-804

  Lantz, R Clark ^a   Hays, Allison M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARSENIC; CARCINOGEN; CIGARETTE SMOKE; DNA; DRINKING WATER; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENOTOXICITY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INGESTION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; TRANSCRIPTION REGULATION;

ADMINISTRATION, INHALATION; ANIMALS; ARSENIC; CARCINOGENS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES, ALVEOLAR; OXIDATIVE STRESS; WATER SUPPLY;

EID: 33845395307     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.1080/03602530600980108     Document Type: Conference Paper

References (20)

1. Abernathy, C. O., Liu, Y., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., Waalkes, M. (1999). Arsenic: health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107:593-597.
2. Aposhian, H. V., Aposhian, M. M. (2006). Arsenic toxicology: five questions. Chem. Res. Toxicol. 19:1-15.
3. Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., Nawroth, P. P. (2005). Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83:876-886.
4. Chen, C. J., Kuo, T. L., Wu, M. M. (1988). Arsenic and cancers (letter). Lancet 414-415.
5. Chiou, H. Y., Hsueh, Y. M., Liaw, K. F., Horng, S. F., Chiang, M. H., Pu, Y. S., Lin, J. S., Huang, C. H., Chen, C. J. (1995). Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55:1296-300.
6. Chiou, J. M., Wang, S. L., Chen, C. J., Deng, C. R., Lin, W., Tai, T. Y. (2005). Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol. 34:936-943.
7. Hays, A., Srinivasan, M. D., Witten, M. L., Carter, D. E., Lantz, R. C. (2006). Cigarette smoke and arsenic synergistically increase DNA oxidation in the lung. Toxicol. Pathol. 34:396-404.
8. Hopenhayn-Rich, C., Biggs, M. L., Smith, A. H. (1998). Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27:561-569.
9. International Agency for Research on Cancer. (IARC). (1987). Arsenic. In Overall Evaluations of Carcinogenicity. An Updating of IARC Monographs 1 to 42. (IARC, Lyon, France). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, Lyon, France. Suppl 7:100-106.
10. Josyula, A. B., Poplin, S., Kurzius-Spencer, M., McClellen, H., Kopplin, M., Sturup, S., Lantz, R. C., Burgess, J. L. (2006). Environmental arsenic exposure and sputum metalloproteinase concentrations. Environ. Res. (in press, available online).
11. Kim, H. S., Manevich, Y., Feinstein, S. I., Pak, J. H., Ho, Y. S., Fisher, A. B. (2003). Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285:L363-L369.
12. Lantz, R. C., Parliman, G., Chen, G. J., Barber, D., Winski, S., Carter, D. E. (1995). Effect of arsenic exposure on alveolar macrophage function. II. Effect of slightly soluble forms of As(III) and As(V). Environ. Res. 68:59-67.
13. Lantz, R. C., Parliman, G., Chen, G. J., Carter, D. E. (1994). Effect of arsenic exposure on alveolar macrophage function. I. Effect of soluble As(III) and As(V). Environ. Res. 67:183-195.
14. Navas-Acien, A., Silbergeld, E. K., Streeter, R. A., Clark, J. M., Burke, T. A., Guallar, E. (2006). Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 114:641-648.
15. Petrick, J. S., Jagadish, B., Mash, E. A., Aposhian, H. V. (2001) Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:651-656.
16. Rossman, T. G. (2003). Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533:37-65.
17. Smith, A. H., Marshall, G., Yuan, Y., Ferreccio, C., Liaw, J., von Ehrenstein, O., Steinmaus, C., Bates, M. N., Selvin, S. (2006). Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114:1293-1296.
18. Wijeweera, J. B., Gandolfi, A. J., Parrish, A., Lantz, R. C. (2001). Sodium arsenite enhances AP-1 and NFκB DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol. Sci. 61:283-294.
19. Wu, M. M., Kuo, T. L., Hwang, Y. H., Chen, C. J. (1989). Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular disease. Am. J. Epidemiol. 130:1123-1132.
20. Zakharyan, R. A., Sampayo-Reyes, A., Healy, S. M., Tsaprailis, G., Board, P. G., Liebler, D. C., Aposhian, H. V. (2001). Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14:1051-1057.